Skip to main content
Tech.euFundingExplorerBeta

One Biosciences

a precision oncology biotech company pioneering clinical grade single-cell tumour profiling

One Biosciences has raised €18M across 2 funding rounds from 9 investors, most recently a Grant round in Sep 2026. Based in Paris, France; active in Healthtech. Data as of 28 Oct 2026.

Total raised
€18M
€18,300,000
Funding rounds
2
Investors
9
distinct backers
Active since
2025-07
latest 2026-09

Funding by year

EUR raised per year · 2026 YTD
One Biosciences — funding by year — interactive chart.
Data table
One Biosciences — funding by year
2025€15M
2026€3.3M

Signals

High confidence
Raise-next likelihood16
base rate 45% for Grant
  • ▼ Raised very recently
  • ▼ Down/flat last round
  • ▼ Low backer re-investment
Exit likelihood15
base rate 11% (2+ rounds)
  • ▼ Young (<3y)
  • ▲ Recent equity round, but funding momentum is down (may be rescue financing)

Timing: too soon vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

2 rounds
DateStageAmountInvestors
2026-09-28Grant€3.3MBpifranceView deal →
2025-07-17Series A€15MAdamed Technology,Blast,Galion.exe,Invus,Kima Ventures,Polytechnique Ventures+2 moreView deal →

Related news

Similar companies

same sector or country

Global coverage: FundingData